![]() |
市場調查報告書
商品編碼
1691758
入境醫療旅遊市場 - 全球產業規模、佔有率、趨勢、機會和預測,按類型、按服務、按地區和競爭細分,2020 年至 2030 年預測Inbound Medical Tourism Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Service By Region and Competition, 2020-2030F |
2024 年全球入境醫療旅遊市場價值為 283.2 億美元,預計在預測期內將實現強勁成長,到 2030 年的複合年成長率為 8.67%。全球入境醫療旅遊市場是一個蓬勃發展的行業,其特點是患者在國外尋求醫療和保健服務的國際流動。近年來,受已開發國家醫療成本上漲、醫療技術進步、網路醫療資訊管道改善等多種因素推動,該市場經歷了顯著成長。
市場概況 | |
---|---|
預測期 | 2026-2030 |
2024 年市場規模 | 283.2 億美元 |
2030 年市場規模 | 462.7 億美元 |
2025-2030 年複合年成長率 | 8.67% |
成長最快的領域 | 牙科服務 |
最大的市場 | 北美洲 |
醫療服務的全球化和國際認可的醫療設施的激增促進了市場的成長。許多國家投入巨資建設最先進的醫療基礎設施,並培訓其醫療專業人員達到國際標準,從而增加了對醫療遊客的吸引力。這些機構提供廣泛的醫療程序,從整容手術和牙科治療等選擇性手術到心臟手術和器官移植等複雜手術。在英國和加拿大等已開發國家,患者在預約和看醫生之間通常要等待至少四週。加拿大有最高比例(36%)的患者需要等待六天或更長時間才能預約醫生。在英國,膝關節重建等非必要手術的等候時間可長達 18 個月,而在澳洲和加拿大,等候時間可長達兩年。
傳染病威脅不斷上升
監管障礙
擴大消費市場
Global Inbound Medical Tourism Market was valued at USD 28.32 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 8.67% through 2030. The Global Inbound Medical Tourism Market represents a thriving industry characterized by the international movement of patients seeking medical treatment and healthcare services in foreign countries. This market has experienced significant growth in recent years, driven by a combination of factors such as increasing healthcare costs in developed nations, advancements in medical technology, and improved accessibility to healthcare information through the internet.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 28.32 Billion |
Market Size 2030 | USD 46.27 Billion |
CAGR 2025-2030 | 8.67% |
Fastest Growing Segment | Dental Service |
Largest Market | North America |
The market's growth is bolstered by the globalization of healthcare services and the proliferation of internationally accredited healthcare facilities. Many countries have invested heavily in building state-of-the-art medical infrastructure and have trained their healthcare professionals to meet international standards, thereby increasing their appeal to medical tourists. These facilities offer a wide range of medical procedures, from elective surgeries like cosmetic surgery and dental treatments to complex surgeries like cardiac procedures and organ transplants. In developed countries like the UK and Canada, patients typically wait at least four weeks between scheduling an appointment and seeing a physician. Canada has the highest percentage of patients (36%) who must wait six days or more for a doctor's appointment. In the UK, waiting lists for non-essential surgeries, such as knee reconstructions, can extend up to 18 months, while in Australia and Canada, the wait can be as long as two years.
Key Market Drivers
Rising Infectious Disease Threats
The Global Inbound Medical Tourism Market is experiencing a notable upswing, and one of the primary driving forces behind this growth is the persistent and escalating threat posed by infectious diseases. In recent years, the world has witnessed a series of infectious disease outbreaks and pandemics that have underscored the critical importance of vaccination and Inbound Medical Tourism in safeguarding public health. These threats have led to a surge in demand for adjuvants, which play a pivotal role in enhancing the efficacy of vaccines and ensuring rapid and robust immune responses. For instance, the World Health Organization (WHO) has released a new report on tuberculosis, revealing that around 8.2 million people were newly diagnosed with TB in 2023-the highest figure recorded since global TB monitoring began in 1995. This marks a significant rise from the 7.5 million cases reported in 2022, making TB the leading infectious disease killer in 2023, surpassing COVID-19.
Key Market Challenges
Regulatory Hurdles
One of the most formidable challenges for Inbound Medical Tourism is the arduous journey through the regulatory approval process. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), require extensive preclinical and clinical data to demonstrate the safety and efficacy of new adjuvants. These rigorous requirements can significantly lengthen the timeline from development to market approval, delaying adjuvant availability and increasing development costs.
Regulatory requirements for Inbound Medical Tourism vary from one country or region to another. This lack of harmonization can create a complex and fragmented landscape for manufacturers seeking global approval. Adhering to multiple sets of regulations necessitates additional resources and can discourage investment in adjuvant research and development. Regulatory agencies often provide limited guidance or specific pathways for the approval of adjuvants. Manufacturers are left to navigate the regulatory process with minimal clear direction, which can result in uncertainty and potential missteps during development and submission. Clarity and consistent guidelines would be instrumental in streamlining the approval process.
Once a vaccine adjuvant is approved and in use, ongoing post-market surveillance is necessary to monitor safety and effectiveness. However, establishing robust surveillance systems and ensuring compliance with reporting requirements can be a regulatory challenge. Failure to do so can result in regulatory actions and a loss of market trust.
Key Market Trends
Expanding Consumer Markets
The Global Inbound Medical Tourism Market is experiencing a significant boost, thanks to the expansion of consumer markets across the globe. As public awareness about the importance of vaccines continues to grow, the demand for effective immunization has surged, propelling the need for vaccine adjuvants. Several factors contribute to the expansion of consumer markets and their positive impact on the Inbound Medical Tourism market. Rising global populations, particularly in emerging economies, are driving an increased demand for vaccines. As more people seek protection against infectious diseases, vaccine manufacturers are ramping up their production. Inbound Medical Tourism play a pivotal role in enhancing the efficacy of vaccines, making them more attractive to a broader consumer base.
The prevalence of infectious diseases remains a global concern. Outbreaks and pandemics like the COVID-19 crisis have highlighted the critical need for vaccines to prevent and control the spread of diseases. This heightened awareness of infectious disease threats has motivated individuals and governments to invest in vaccination programs, further fueling the demand for adjuvanted vaccines.
Expanding consumer markets also encompasses a growing awareness of vaccination's role in safeguarding public health. As healthcare education becomes more accessible, people are becoming better informed about the benefits of vaccination, not only for individual protection but also for community immunity. This increased understanding has led to greater vaccine acceptance and a willingness to opt for vaccines enhanced with adjuvants for better protection.
In this report, the Global Inbound Medical Tourism Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Inbound Medical Tourism Market.
Global Inbound Medical Tourism Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: